Alnylam Pharma (ALNY) Tops Q2 EPS by 91c
Tweet
Share
E-mail
Get Alerts ALNY Hot Sheet
Price: $244.32 +1.99%
EPS Growth %: -39.0%
Financial Fact:
Total operating expenses: 101.16M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -39.0%
Financial Fact:
Total operating expenses: 101.16M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of $0.32, $0.91 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $773.69 million versus the consensus estimate of $643.2 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Wabtec signs $700M rail services deal for Guinea mining project
- Raytheon wins $34 million contract for V-22 software support
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
